First Cobalt, Acasti Pharma and More Earnings Reports this Week (Jan 20-24)

He shorted the name a couple of years ago, but has almost no position now. It is highly speculative. There is a lot of resource and it will take a lot of money to take it into production.

A high-quality company, but it has had an extraordinary run. His view is that the price is ahead of itself.

Cobalt is attractive but this is not a cheap producer, because they're in Canada and not Russia or Congo.

They just partnered with a private equity group. The company is now 45% owned by private equity. They completed their first pour in the Yukon and are moving towards commercial production. The problem is the private equity partner will have a lot of say in the operations. This will keep him out as an investor.

He is not a gold bug however he is big on structural themes and golds have been making a big turn. It would have the largest new deposit in the world. Theirs is a great asset in a group that is hated. He thinks we are into a reflationary cycle and the golds are set…

They are a recruitment company. It’s not very exciting. It was 45 cents a few years ago, but has been pretty flat since 2013. They pay a nice dividend, the stock hardly trades (about 12000 share volume). It’s profitable and well-managed. He would be interested in the stock at 75 cents but it is so…

CP-T vs. CNR-T. CP-T was at $220 in 2014 and broke out from there last year. It consolidated for 5 years. This is a great way to participate in economic growth.

(A Top Pick Feb 14/19, Up 5%) Kinder Morgan Canada was purchased by Pembina Pipeline. This was the TMX project. He was hoping for a better price in the acquisition, so the return was muted.

Not a long-term hold. Near-term is okay. It's quasi-cyclical. If housing dips...oh boy. He owned this 30 years ago. A good operator with good product, but the macro environment is not good. If a recession comes, sell. Hold.

(A Top Pick Jan 28/19, Down 37%) They are very much encouraged by the latest results. The company has started buying back shares. It is suffering from some tax loss selling. There is huge upside and very little downside. He just bought a lot more.

(A Top Pick Dec 31/18, Down 5%) The uranium stocks (and new uranium supplies) won't move up until the commodity rises above $50. It's trading under $30 now. Uranium demand is probably 40% higher than supply. Demand is growing as new nuclear reactors increase; there's demand, but there's an inventory overhang that's pressuring the price.…

Is there any growth in the investment business? AGF's balance sheet is too big for what they earn. Potential write-offs must happen to bring that down. Asset management businesses are being killed. $10.84 is his target price--lots of upside and they can cover their dividend.

He would not short it or buy it. It had a big run this year on the idea of it getting into online gambling. He thinks it is real and could turn into a good situation but they will need some money to fund this roll out so see how they finance it. It is…

They're working on a phase two test of a new drug, but the results are delayed, which has hammered the stock by half, though it's moved up 16% today. Results should be released in mid/late-January and he expects them to be positive. The drug will address a huge population who suffers high cholesterol. He sees…

For years NEPT was in partnerships where they were extracting Omega-3 oils from krill oil and selling that to consumers. Now they're taking that extraction technology and applying it to the cannabis oil market. He's in a wait-and-see spots. The fundamentals don't back the move up in the stock. He has a small short on…

They had a cyber theft – 9 Million out of there bank but insurance covered it. He likes it. It is speculative and is a roll up strategy.

Thinks they had a problem with a big Canadian government contract this spring, and the stock dropped dramatically. He doesn’t think they will be making any money here.